Shrestha, R. (2020) “Induced pluripotent stem cells are Japanese brand sources for therapeutic cells to pretrial clinical research”, Progress in Stem Cell, 7(1), pp. 296-303. doi: https://doi.org/10.15419/psc.v7i1.409.